SLXNW Silexion Therapeutics Corp - Warrant
NASDAQ · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 14, 2026
$0,01
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,01mínimo 52 semanas
$0,08máximo 52 semanas
Capitalización Bursátil (MRQ)
$7.1K
P/E
0.0
BPA
$8.96
tus insignias
Rango 52S
$0–$0
Calificación del Analista
·
Precio Objetivo
·
P/E
0.0
ROE
1718.9%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
SLXNW Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.01
Capitalización Bursátil (MRQ)
$7.1K
P/E
0.0
BPA
$8.96
ROE
1718.9%
Rango 52S
$0–$0
SLXNW Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$8.962023-12-31 → 2025-12-31
Flujo de caja libre$-11M2024-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | SLXNW | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | 0.0 | · | · | · | |
| P/C (MRQ) | 0.2 | · | · | · | |
| Price / FCF (Precio / FCF) | -0.0 | · | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -0.0 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.0 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | SLXNW | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -236.4% | · | · | · | |
| ROE | 1718.9% | · | · | · | |
| ROIC | -447.0% | · | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | SLXNW | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 0.9 | · | · | · | |
| Quick Ratio (Ratio Rápido) | 2.2 | · | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | SLXNW | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| EPS YoY (EPS interanual) | -97.7% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $7M | $6M | $4M | |
| SG&A Expense | $4M | $7M | $973.0K | |
| Operating Expenses | $12M | $13M | $5M | |
| Operating Income | $-12M | $-13M | $-5M | |
| Interest Income | $155.0K | $28.0K | $153.0K | |
| Other Non-op | $13.0K | $7.0K | $6.0K | |
| Pretax Income | $-12M | $-17M | $-5M | |
| Income Tax | $3.0K | $10.0K | $32.0K | |
| Net Income | $-12M | $-17M | $-5M | |
| EPS (Basic) | $8.96 | $394.94 | $44.23 | |
| EPS (Diluted) | $8.96 | $394.94 | $44.23 | |
| Shares (Basic) | 1,329,515 | 41,635 | 111,726 | |
| Shares (Diluted) | 1,329,515 | 41,635 | 111,726 | |
| EBITDA | $-12M | $-13M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $6M | $1M | $5M | |
| Prepaid Expense | $570.0K | $966.0K | $335.0K | |
| Other Current Assets | $49.0K | $62.0K | $24.0K | |
| Current Assets | $7M | $2M | $5M | |
| PP&E (Net) | $25.0K | $30.0K | $49.0K | |
| PP&E (Gross) | $108.0K | $99.0K | $133.0K | |
| Accum. Depreciation | $83.0K | $69.0K | $84.0K | |
| Total Assets | $7M | $3M | $5M | |
| Accounts Payable | $787.0K | $929.0K | $319.0K | |
| Accrued Liabilities | $859.0K | · | · | |
| Current Liabilities | $3M | $4M | $2M | |
| Capital Leases | $286.0K | $368.0K | $59.0K | |
| Total Liabilities | $5M | $7M | $2M | |
| Common Stock | $42.0K | $2.0K | · | |
| Paid-in Capital | $58M | $39M | $11M | |
| Retained Earnings | $-55M | $-43M | $-27M | |
| Stockholders' Equity | $3M | $-4M | $-15M | |
| Liabilities + Equity | $7M | $3M | $5M | |
| Shares Outstanding | 312,665 | 123,290,000 | 97,120,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $134.0K | $6M | $130.0K | |
| Operating Cash Flow | $-11M | $-8M | $-5M | |
| CapEx | $9.0K | $22.0K | $12.0K | |
| Investing Cash Flow | $-14.0K | $-22.0K | $573.0K | |
| Financing Cash Flow | $16M | $5M | $522.0K | |
| Free Cash Flow | $-11M | $-8M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -236.4% | -555.3% | · | |
| ROE | 1718.9% | 169.7% | · | |
| ROIC | -447.0% | 315.3% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 2.4 | 0.6 | · | |
| Quick Ratio | 2.2 | 0.3 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $0.00 | $-0.00 | · | |
| Cash Flow / Share | $-8.14 | $-13.46 | · | |
| Cash / Share | $0.00 | $0.00 | · | |
| EPS (TTM) | $8.96 | $394.94 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| EPS YoY | -97.7% | 792.9% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-12M | $-17M | · | |
| Market Cap | $103M | · | · | |
| P/E | 0.0 | · | · | |
| P/B | 39.6 | · | · | |
| P / Tangible Book | 39.6 | · | · | |
| P / Cash Flow | -9.5 | · | · | |
| P / FCF | -9.5 | · | · | |
| Earnings Yield | 27151.5% | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $2M | $1M | $590.0K | $871.0K | $3M | $766.0K | $961.0K | $1M | $535.0K | $1M | |
| SG&A Expense | $1M | $1M | $1M | $1M | $1M | $1M | $5M | $619.0K | $289.0K | $471.0K | $196.0K | $179.0K | |
| Operating Expenses | $4M | $4M | $3M | $2M | $2M | $2M | $8M | $1M | $1M | $2M | $731.0K | $1M | |
| Operating Income | $-4M | $-4M | $-3M | $-2M | $-2M | $-2M | $-8M | $-1M | $-1M | $-2M | $-731.0K | $-1M | |
| Interest Income | $14.0K | $70.0K | $39.0K | $44.0K | $2.0K | $3.0K | $0 | $6.0K | $19.0K | · | · | · | |
| Other Non-op | $-115.0K | $6.0K | $4.0K | $260.0K | $3.0K | $2.0K | $3.0K | $2.0K | $0 | $1.0K | $1.0K | $3.0K | |
| Pretax Income | $-4M | $-4M | $-3M | $-2M | $-2M | $-2M | $-12M | $-1M | $-1M | $-2M | $-803.0K | $-2M | |
| Income Tax | · | $0 | $0 | $3.0K | · | $1.0K | $2.0K | $2.0K | $5.0K | $6.0K | $6.0K | $10.0K | |
| Net Income | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-12M | $-1M | $-1M | $-2M | $-809.0K | $-2M | |
| EPS (Basic) | $5.17 | $1.50 | $2.88 | $43.19 | $0.26 | $-89.40 | $274.25 | $197.80 | $12.29 | $41.03 | $0.78 | $6.54 | |
| EPS (Diluted) | $5.17 | $1.50 | $2.88 | $43.19 | $0.26 | $-89.40 | $274.25 | $197.80 | $12.29 | $41.03 | $0.78 | $6.54 | |
| Shares (Basic) | 687,353 | · | 1,132,658 | 57,952 | 6,779,205 | · | 43,213 | 7,442 | 111,726 | · | 1,005,531 | 252,462 | |
| Shares (Diluted) | 687,353 | · | 1,132,658 | 57,952 | 6,779,205 | · | 43,213 | 7,442 | 111,726 | · | 1,005,531 | 252,462 | |
| EBITDA | $-4M | · | $-3M | $-2M | $-2M | · | $-8M | $-1M | · | · | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $6M | $9M | $3M | $6M | $1M | $2M | $2M | · | $5M | · | · | |
| Prepaid Expense | $1M | $570.0K | $2M | $2M | $1M | $966.0K | $944.0K | $527.0K | · | $335.0K | · | · | |
| Other Current Assets | $111.0K | $49.0K | $47.0K | $63.0K | $58.0K | $62.0K | $80.0K | $66.0K | · | $24.0K | · | · | |
| Current Assets | $4M | $7M | $11M | $5M | $8M | $2M | $3M | $2M | · | $5M | · | · | |
| PP&E (Net) | $20.0K | $25.0K | $26.0K | $30.0K | $32.0K | $30.0K | $35.0K | $40.0K | · | $49.0K | · | · | |
| PP&E (Gross) | · | $108.0K | · | · | · | $99.0K | · | · | · | $133.0K | · | · | |
| Accum. Depreciation | · | $83.0K | · | · | · | $69.0K | · | · | · | $84.0K | · | · | |
| Total Assets | $4M | $7M | $12M | $6M | $8M | $3M | $3M | $3M | · | $5M | · | · | |
| Accounts Payable | · | $787.0K | $946.0K | $692.0K | $722.0K | $929.0K | $799.0K | $281.0K | · | $319.0K | · | · | |
| Accrued Liabilities | $933.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $4M | $3M | $3M | $2M | $2M | $4M | $4M | $2M | · | $2M | · | · | |
| Capital Leases | $226.0K | $286.0K | $311.0K | $337.0K | $334.0K | $368.0K | $0 | $8.0K | · | $59.0K | · | · | |
| Total Liabilities | $4M | $5M | $5M | $6M | $6M | $7M | $8M | $2M | · | $2M | · | · | |
| Common Stock | $160.0K | $42.0K | $42.0K | $8.0K | $8.0K | $2.0K | $1.0K | $1.0K | · | · | · | · | |
| Paid-in Capital | $61M | $58M | $58M | $48M | $48M | $39M | $37M | $11M | · | $11M | · | · | |
| Retained Earnings | $-61M | $-55M | $-51M | $-47M | $-45M | $-43M | $-42M | $-30M | · | $-27M | · | · | |
| Stockholders' Equity | $44.0K | $3M | $7M | $120.0K | $3M | $-4M | $-5M | $-18M | · | $-15M | · | · | |
| Liabilities + Equity | $4M | $7M | $12M | $6M | $8M | $3M | $3M | $3M | · | $5M | · | · | |
| Shares Outstanding | 1,179,844 | 3,126,651,000 | 3,126,642 | 579,536 | 8,691,971 | 123,290,000 | 11,180,031 | 219,354 | · | 97,120,000 | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $197.0K | $38.0K | $38.0K | $37.0K | $21.0K | $0 | $6M | $32.0K | $32.0K | $34.0K | $32.0K | $32.0K | |
| Operating Cash Flow | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-1M | $-2M | $-1M | $-685.0K | $-2M | |
| CapEx | $0 | $2.0K | $0 | $1.0K | $6.0K | $0 | $16.0K | $0 | $6.0K | $4.0K | $6.0K | $2.0K | |
| Investing Cash Flow | $-1.0K | $-7.0K | $0 | $-1.0K | $-6.0K | $0 | $-16.0K | $0 | $-6.0K | $-4.0K | $72.0K | $-2.0K | |
| Stock Issued | $2M | · | $0 | $0 | · | · | $620.0K | · | · | · | · | · | |
| Net Stock Activity | $2M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $-221.0K | $9M | $-195.0K | $7M | $2M | $3M | $0 | · | $0 | $0 | $522.0K | |
| Free Cash Flow | $-3M | · | $-3M | $-3M | $-2M | · | $-3M | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -70.7% | · | -44.4% | -60.2% | -41.8% | · | -768.4% | -117.9% | · | · | · | · | |
| ROE | -4330.5% | · | -272.1% | 27.6% | -134.2% | · | 518.0% | 16.3% | · | · | · | · | |
| ROIC | · | · | -47.2% | -1905.6% | · | · | 175.5% | 7.6% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | · | 4.0 | 2.4 | 3.2 | · | 0.9 | 1.0 | · | · | · | · | |
| Quick Ratio | 0.6 | · | 3.3 | 1.6 | 2.6 | · | 0.6 | 0.7 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.04 | · | $2.23 | $0.21 | $0.30 | · | $-0.41 | $-83.23 | · | · | · | · | |
| Cash Flow / Share | $-4.26 | · | $-2.51 | $-4.33 | $-0.36 | · | $-0.46 | $-4.25 | · | · | · | · | |
| Cash / Share | $1.89 | · | $2.96 | $5.98 | $0.71 | · | $0.18 | $7.74 | · | · | · | · | |
| EPS (TTM) | $10.40 | · | $-39.49 | $231.88 | $386.49 | · | $525.37 | $251.90 | $60.64 | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-14M | · | $-9M | $-18M | $-17M | · | $-16M | $-5M | $-6M | · | · | · | |
| Market Cap | $39.4K | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 31137.7% | · | · | · | · | · | · | · | · | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|
| Beneficio neto | $-12M | · | $-17M | · | · |
| EPS Diluido | $8.96 | · | $394.94 | · | · |
| Métrica | 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|
| Ratio corriente | 2.4 | · | 0.6 | · | · |
| Ratio Rápido | 2.2 | · | 0.3 | · | · |
| Métrica | 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-11M | · | $-8M | · | · |
Propietarios institucionales (13F) 23 declarantes · $141K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
23
Valor en tenencia
$141K
Nuevas posiciones
1
Posiciones cerradas
1
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 1 (+1 vs trimestre anterior) | 1 (-2 vs trimestre anterior) | 1 (0 vs trimestre anterior) | 1 (0 vs trimestre anterior) | +81K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| DeepCurrents Investment Group LLC | $36 167 | 14 183 | 25,73% | Opción de compra |
| Oasis Management Co Ltd. | $28 333 | 11 111 | 20,16% | Acciones |
| Polar Asset Management Partners Inc. | $20 817 | 743 475 | 14,81% | Acciones |
| Linden Advisors LP | $9 484 | 337 500 | 6,75% | Acciones |
| CLEAR STREET LLC | $8 988 | 219 765 | 6,39% | Acciones |
| ARISTEIA CAPITAL, L.L.C. | $6 635 | 236 546 | 4,72% | Acciones |
| Clear Street Group Inc. | $6 632 | 218 165 | 4,72% | Acciones |
| SECURITY BENEFIT LIFE INSURANCE CO /KS/ | $4 560 | 150 000 | 3,24% | Acciones |
| GOLDMAN SACHS GROUP INC | $3 803 | 125 103 | 2,71% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 799 | 92 073 | 1,99% | Acciones |
| JANE STREET GROUP, LLC | $2 277 | 74 910 | 1,62% | Acciones |
| PICTON MAHONEY ASSET MANAGEMENT | $1 738 | 57 175 | 1,24% | Acciones |
| Context Capital Management, LLC | $1 556 | 51 183 | 1,11% | Acciones |
| TENOR CAPITAL MANAGEMENT Co., L.P. | $1 520 | 50 000 | 1,08% | Acciones |
| GABELLI & Co INVESTMENT ADVISERS, INC. | $1 160 | 38 150 | 0,83% | Acciones |
| DUPONT CAPITAL MANAGEMENT CORP | $988 | 32 500 | 0,70% | Acciones |
| NEUBERGER BERMAN GROUP LLC | $959 | 31 552 | 0,68% | Acciones |
| GABELLI FUNDS LLC | $927 | 30 496 | 0,66% | Acciones |
| STIFEL FINANCIAL CORP | $486 | 16 000 | 0,35% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $380 | 12 500 | 0,27% | Opción de compra |
| COBBLESTONE CAPITAL ADVISORS LLC /NY/ | $352 | 10 000 | 0,25% | Acciones |
| Kepos Capital LP | $3 | 100 000 | 0,00% | Acciones |
| Mint Tower Capital Management B.V. | $1 | 25 000 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Ilan Levin, Moringa Partners Ltd, Moringa Sponsor, LP ×2 presentaciones | 28 de septiembre de 2026 | 17,70% | Enmienda | · | SEC |
| Moringa Sponsor, LP, Moringa Partners Ltd, Ilan Levin | 23 de junio de 2026 | 10,60% | Enmienda | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 14, 2026